After showing the good, the pharmaceutical company again welcomed the 10th consecutive fall stop

"Don't move the stock!" Drug companies are good! "Isn't it? Don't panic, keep falling! "In March 2019, pharmaceutical company Baijian announced the failure of the development of an Alzheimer's drug, Adakama monoantigen, on the same day that the stock plunged nearly 28 percent, reducing its market value by $18 billion;
but this time a joint Japanese pharmaceutical company, Wesser, announced that the joint development of Adumama single resistance significantly reduced the severity of Alzheimer's disease, the company's shares immediately rose nearly 40 percent.
do you mean by these old things? The stock market doesn't hesitate because of the news that the same company has the same drug, and always follows a principle: normal stock price fluctuations are bound to react to the positives and positives of the news.
if a company releases good news, the stock still falls? First, the good is too weak, the edge can not rise up the trend of defeat;
25, a pharmaceutical company announced that xx Bio, a wholly owned subsidiary, and xx companies in the United States signed the Second Amendment to the Production Agreement.
involving 900 million safety injections and safety syringes, with a total value of about 500 million yuan.
this is a big bill, and both parties are real names, there is security.
is worth $975 million, compared with the $975 million contract that JF Technologies disclosed on May 18 with a U.S. company.
The latter is just an announcement, as of August 7, let the stock in the secondary market, the share price rose from 13.34 yuan / share to 17.38 yuan / share, the period rose as much as 43%, compared with the way to go.
but a pharmaceutical this good, did not cause a rebound in the stock, and even on the morning of the 29th, the stock appeared for ten consecutive days of decline.
map source: with the flower shun in this thrilling fall, there is bound to be retail and institutional copy bottom, there will also be people cutting meat.
this isn't the first time the drug's stock has fallen in a row, and it's not the first time it's made the news because of the stock.
in December 2019, CCTV experts said the stock market situation is more obvious.
July 2020, CCTV revealed that in June, a number of investors, after watching the live webcast, bought the stock price high on the relevant stocks, the next day even eat four stop, heavy losses.
, of course, every time a business says there are no major unreclosed matters.
But the profit is really declining, from the product business, medical services, chemical pharmaceuticals and medical equipment research and development, production and sales, according to reason this year in addition to cold drug sales, other drugs are relatively stable, in addition to pharmaceutical stocks are more competitive.
but profits have fallen, with net profit margins falling for the second consecutive year in 2018 and 2019, with gross margins of 48 per cent in 2015 and 9 per cent in 2019.
is not profitable, a fall in stocks is inevitable.
't work with the product line, what about the hospital? From the acquisition of a 51% stake in Hainan's anti-aging centre to a 100 per cent stake in Spain's in vitro diagnostics, making money may not be enough, but it has cost more than $600m.
some money invested, the stock market will shout well;
hospitals and companies that invest in the company's performance is not as good as expected, it is bound to affect the overall stock price.
big mergers and acquisitions, especially in debt, but it's going to go the other side.
no fist products to ensure that the basic profit does not fall, relying on investment to pull, but investment is not a steady income.
may be fresh for a moment, but it's not always in your hands.
like Hengrui Pharmaceuticals, such as the announcement of the market value of the magic, that is the research and development pipeline up, a new drug clinical registration step by step for the camp, are relying on products to fight the world.
don't think you rely on stocks because of their high market value.
stock market is equivalent to the bubble above the beer, the real craft is in the wine, people's cups of foam high, more by the wine on the bottom of the top.
adults than alcohol, the amount of alcohol is never looking at the bubble.
。